# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-25-007320
Filing Date
2025-03-12
Accepted
2025-03-12 17:23:19
Documents
117
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | zvra20241231_10k.htm iXBRL | 10-K | 2795129
2 | EXHIBIT 4.5 | ex_725363.htm | EX-4.5 | 49338
3 | EXHIBIT 10.13 | ex_784725.htm | EX-10.13 | 170021
4 | EXHIBIT 10.14 | ex_784730.htm | EX-10.14 | 175258
5 | EXHIBIT 10.16.1 | ex_784732.htm | EX-10.16 | 13308
6 | EXHIBIT 19.0 | ex_785339.htm | EX-19.0 | 60626
7 | EXHIBIT 23.1 | ex_725367.htm | EX-23.1 | 8030
8 | EXHIBIT 31.1 | ex_725368.htm | EX-31.1 | 14499
9 | EXHIBIT 31.2 | ex_725369.htm | EX-31.2 | 14512
10 | EXHIBIT 32.1 | ex_725370.htm | EX-32.1 | 7358
11 | EXHIBIT 32.2 | ex_725371.htm | EX-32.2 | 7491
| Complete submission text file | 0001437749-25-007320.txt |  | 12610951

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA | zvra-20241231.xsd | EX-101.SCH | 105532
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | zvra-20241231_cal.xml | EX-101.CAL | 92062
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | zvra-20241231_def.xml | EX-101.DEF | 727433
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | zvra-20241231_lab.xml | EX-101.LAB | 622905
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | zvra-20241231_pre.xml | EX-101.PRE | 771930
120 | EXTRACTED XBRL INSTANCE DOCUMENT | zvra20241231_10k_htm.xml | XML | 1743120

Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36913 | Film No.: 25732819
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)